News

Home News

17

May2016

CADTH Releases Recommendations Report for Anti-Vascular Endothelial Growth Factor Drugs for Retinal Conditions

/ CADTH, News, What's New
On May 5, 2016, the Canadian Agency for Drugs and Technologies in Health (CADTH) released a Recommendations Report on its ... Read More

03

May2016

The PMPRB Releases its April 2016 NEWSletter

/ PMPRB, What's New
The Patented Medicine Prices Review Board (PMPRB) has released its April 2016 NEWSletter. Some recent changes include: Public Consultation on PMPRB ... Read More

22

Apr2016

New Drug Review Process Developed by INESSS for Stable Blood Products

/ INESSS, Quebec, What's New
To meet the needs of Quebec’s Ministry of Health and Social Services (MSSS), the Institut national d’excellence en santé et ... Read More

19

Apr2016

The pan-Canadian Pharmaceutical Alliance (pCPA) Releases its April 1st, 2016 Update

/ pCPA, What's New
On April 1, 2016, the pan-Canadian Pharmaceutical Alliance (pCPA) issued the First Principles for Subsequent Entry Biologics (SEBs) to guide ... Read More

11

Apr2016

The pCPA Releases First Principles for Subsequent Entry Biologics

/ pCPA, What's New
On April 1, 2016, the pan-Canadian Pharmaceutical Alliance (pCPA) issued manufacturers a notification of first principles for subsequent entry biologics ... Read More

30

Mar2016

New Implementation Dates for Revisions to the Procedure for Voluntary Withdrawal and Providing CDR Review Team’s Responses

/ CADTH, CDEC, CDR, What's New
Due to a high workload volume and ensuring submissions are reviewed in a timely manner, CADTH is deferring the effective ... Read More

30

Mar2016

Minimum Period of 120 Calendar Days for Advance Notification of Anticipated Submissions and Resubmissions for CADTH’s CDR and pCODR Programs

/ CADTH, CDEC, CDR, pCODR, What's New
Recommendation Framework for CADTH Common Drug Review (CDR) and pan-Canadian Oncology Drug Review (pCODR) Programs In collaboration with the participating jurisdictions ... Read More

24

Mar2016

The PMPRB to Implement Next Steps Regarding the Compendium of Policies, Guidelines and Procedures in June 2016

/ PMPRB, What's New
In December 2015, the Patented Medicine Prices Review Board (PMPRB) posted a Notice and Comment seeking stakeholder comments on ... Read More